Vaccination against some E. coli Serotypes Isolated from Diseased Broiler Chickens with Chronic Respiratory Disease (CRD)

Dahshan, AL Hussien M.; Mohamed, Asmaa

doi:10.21608/jvmr.2016.43247

Cited by 1 publication

(1 citation statement)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Unvaccinated chicken challenged with APEC O 78 showed severe heterophil and mononuclear cell infiltration, hyperplasia of the epithelium, and the presence of necrotic foci in the air sacs, liver, pericardium, and myocardium in varying combinations. Similar histopathological changes were seen but with lesser degrees in the vaccinated birds, suggesting that, though live attenuated vaccine provides clinical protection against the challenge, it did not completely prevent pathological lesions [ 37 , 38 ]. In the treated groups the recorded histopathological findings were mild at 2 dpi and increased by 7 dpi.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of Live Attenuated Vaccine and Commercially Available Lectin against Avian Pathogenic E. coli Infection in Broiler Chickens

El-Mawgoud¹,

El-Nahass

Shany

et al. 2020

Veterinary Sciences

View full text Add to dashboard Cite

In this study, the protective efficacy of an E. coli live attenuated vaccine was compared to the preventive administration of lectin preparation before the challenge. Two hundred broiler chicks were divided into eight equal groups. The first group was used as a negative control group. Three groups were vaccinated at day 1 with the avian colibacillosis live vaccine of which one group served as a vaccinated nonchallenged group. Another two groups were treated with lectin product (0.5 mL/L drinking water) for three days before the challenge. The last two groups served as challenge control for either E. coli O78 or O125 strains. The challenge was conducted at three weeks of age with either homologous O78 or heterologous O125 E. coli strains, using 0.5 mL/bird of each avian pathogenic E. coli (APEC) strain (~108 colony forming units “CFU”/mL)/subcutaneously. The bodyweight and feed conversion ratios (FCR) were calculated for four weeks. Clinical signs and gross and histopathological lesions were scored at two and seven days post inoculation (dpi). The heart and liver of euthanized chickens at 2 dpi were removed aseptically and homogenized to evaluate pathogenic E. coli colonization. Results showed that live avian colibacillosis vaccine reduced mortalities and APEC colonization in the homologous challenge group but not in the heterologous challenge group. Lectin-treated groups showed 20% and 16% mortality after challenge with E. coli O78 and O125, respectively, and both groups showed performance parameters, clinical signs, and histopathological lesion scores comparable to the negative control group, with variable E. coli colonization of heart and liver. The study demonstrated the efficacy of live attenuated avian colibacillosis vaccine against homologous but not heterologous APEC challenge in broiler chickens. The lectin-containing products can be used as a preventive medication to reduce the clinical impacts of colibacillosis regardless of the challenge strain. Standardization of the evaluation parameters for APEC vaccines is recommended.

show abstract

Section: Discussionmentioning

confidence: 99%